{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:19:58Z","timestamp":1793038798905,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-066"],"award-info":[{"award-number":["2022-PUMCH-B-066"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-066"],"award-info":[{"award-number":["2022-PUMCH-B-066"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-066"],"award-info":[{"award-number":["2022-PUMCH-B-066"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-066"],"award-info":[{"award-number":["2022-PUMCH-B-066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03812-5","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:01:27Z","timestamp":1712761287000},"page":"1041-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"85","author":[{"given":"Nengwen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"3812_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"R.L. Siegel, K.D. Miller, N.S. Wagle et al. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023). https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J. Clin."},{"key":"3812_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00268-022-06770-z","volume":"47","author":"Y Ito","year":"2023","unstructured":"Y. Ito, A. Miyauchi, M. Fujishima et al. Thyroid-stimulating hormone, age, and tumor size are risk factors for progression during active surveillance of low-risk papillary thyroid microcarcinoma in adults. World J. Surg. 47, 392\u2013401 (2023). https:\/\/doi.org\/10.1007\/s00268-022-06770-z","journal-title":"World J. Surg."},{"key":"3812_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3349\/ymj.2012.53.5.924","volume":"53","author":"BY Kim","year":"2012","unstructured":"B.Y. Kim, C.H. Jung, J.W. Kim et al. Impact of clinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Yonsei Med. J. 53, 924\u2013930 (2012). https:\/\/doi.org\/10.3349\/ymj.2012.53.5.924","journal-title":"Yonsei Med. J."},{"key":"3812_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Y. Ito, A. Miyauchi, H. Inoue et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34, 28\u201335 (2010). https:\/\/doi.org\/10.1007\/s00268-009-0303-0","journal-title":"World J. Surg."},{"key":"3812_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","volume":"40","author":"A Miyauchi","year":"2016","unstructured":"A. Miyauchi, Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J. Surg. 40, 516\u2013522 (2016). https:\/\/doi.org\/10.1007\/s00268-015-3392-y","journal-title":"World J. Surg."},{"key":"3812_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/thy.2020.0330","volume":"31","author":"I Sugitani","year":"2021","unstructured":"I. Sugitani, Y. Ito, D. Takeuchi et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma. Thyroid 31, 183\u2013192 (2021). https:\/\/doi.org\/10.1089\/thy.2020.0330","journal-title":"Thyroid"},{"key":"3812_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"3812_CR8","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","volume":"105","author":"E Molinaro","year":"2020","unstructured":"E. Molinaro, M.C. Campopiano, L. Pieruzzi et al. Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center. J. Clin. Endocrinol. Metab. 105, e172\u2013e180 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz113","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR9","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","volume":"8","author":"AS Ho","year":"2022","unstructured":"A.S. Ho, S. Kim, C. Zalt et al. Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial. JAMA Oncol. 8, 1588\u20131596 (2022). https:\/\/doi.org\/10.1001\/jamaoncol.2022.3875","journal-title":"JAMA Oncol."},{"key":"3812_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/s2213-8587(16)30180-2","volume":"4","author":"S Leboulleux","year":"2016","unstructured":"S. Leboulleux, R.M. Tuttle, F. Pacini et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 4, 933\u2013942 (2016). https:\/\/doi.org\/10.1016\/s2213-8587(16)30180-2","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3812_CR11","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1210\/jc.2017-01832","volume":"102","author":"TE Angell","year":"2017","unstructured":"T.E. Angell, C.M. Vyas, M. Medici et al. Differential growth rates of benign vs. malignant thyroid nodules. J. Clin. Endocrinol. Metab. 102, 4642\u20134647 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01832","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Y. Ito, A. Miyauchi, M. Kihara et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24, 27\u201334 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0367","journal-title":"Thyroid"},{"key":"3812_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jamaoto.2020.0368","volume":"146","author":"A Koshkina","year":"2020","unstructured":"A. Koshkina, R. Fazelzad, I. Sugitani et al. Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and meta-analysis. JAMA Otolaryngol. Head Neck Surg. 146, 552\u2013560 (2020). https:\/\/doi.org\/10.1001\/jamaoto.2020.0368","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"3812_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/ERC-21-0403","volume":"29","author":"HI Kim","year":"2022","unstructured":"H.I. Kim, M. Jin, N.G. Ko et al. Effect of TSH levels during active surveillance of PTMC according to age. Endocr. Relat. Cancer 29, 191\u2013200 (2022). https:\/\/doi.org\/10.1530\/ERC-21-0403","journal-title":"Endocr. Relat. Cancer"},{"key":"3812_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1210\/jc.2017-01775","volume":"103","author":"HI Kim","year":"2018","unstructured":"H.I. Kim, H.W. Jang, H.S. Ahn et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J. Clin. Endocrinol. Metab. 103, 446\u2013451 (2018). https:\/\/doi.org\/10.1210\/jc.2017-01775","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR16","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1089\/thy.2021.0614","volume":"32","author":"EK Lee","year":"2022","unstructured":"E.K. Lee, J.H. Moon, Y. Hwangbo et al. Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea. Thyroid 32, 1328\u20131336 (2022). https:\/\/doi.org\/10.1089\/thy.2021.0614","journal-title":"Thyroid"},{"key":"3812_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00268-013-2335-8","volume":"38","author":"I Sugitani","year":"2014","unstructured":"I. Sugitani, Y. Fujimoto, K. Yamada, Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J. Surg. 38, 673\u2013678 (2014)","journal-title":"World J. Surg."},{"key":"3812_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"Bmj"},{"key":"3812_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"D.F. Stroup, J.A. Berlin, S.C. Morton et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283, 2008\u20132012 (2000). https:\/\/doi.org\/10.1001\/jama.283.15.2008","journal-title":"Jama"},{"key":"3812_CR20","doi-asserted-by":"publisher","unstructured":"M.R. Megens, L. Churilov, and V. Thijs. New-onset atrial fibrillation after coronary artery bypass graft and long-term risk of stroke: a meta-analysis. J. Am. Heart Assoc. 6(2017). https:\/\/doi.org\/10.1161\/jaha.117.007558","DOI":"10.1161\/jaha.117.007558"},{"key":"3812_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"J.P. Higgins, S.G. Thompson, J.J. Deeks et al. Measuring inconsistency in meta-analyses. Bmj 327, 557\u2013560 (2003). https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"Bmj"},{"key":"3812_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"M. Egger, G. Davey Smith, M. Schneider et al. Bias in meta-analysis detected by a simple, graphical test. Bmj 315, 629\u2013634 (1997). https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"Bmj"},{"key":"3812_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1210\/jc.2016-4026","volume":"102","author":"H Kwon","year":"2017","unstructured":"H. Kwon, H.S. Oh, M. Kim et al. Active surveillance for patients with papillary thyroid microcarcinoma: a single center\u2019s experience in korea. J. Clin. Endocrinol. Metab. 102, 1917\u20131925 (2017). https:\/\/doi.org\/10.1210\/jc.2016-4026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230006","volume":"309","author":"JY Lee","year":"2023","unstructured":"J.Y. Lee, J.H. Kim, Y.K. Kim et al. US predictors of papillary thyroid microcarcinoma progression at active surveillance. Radiology 309, e230006 (2023). https:\/\/doi.org\/10.1148\/radiol.230006","journal-title":"Radiology"},{"key":"3812_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.surg.2017.03.028","volume":"163","author":"A Miyauchi","year":"2018","unstructured":"A. Miyauchi, T. Kudo, Y. Ito et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery 163, 48\u201352 (2018). https:\/\/doi.org\/10.1016\/j.surg.2017.03.028","journal-title":"Surgery"},{"key":"3812_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/thy.2015.0393","volume":"26","author":"Y Ito","year":"2016","unstructured":"Y. Ito, A. Miyauchi, T. Kudo et al. Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. Thyroid 26, 156\u2013160 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0393","journal-title":"Thyroid"},{"key":"3812_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1089\/thy.2013.0527","volume":"24","author":"H Shindo","year":"2014","unstructured":"H. Shindo, N. Amino, Y. Ito et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 24, 840\u2013844 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0527","journal-title":"Thyroid"},{"key":"3812_CR28","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00268-021-06185-2","volume":"45","author":"R Nagaoka","year":"2021","unstructured":"R. Nagaoka, A. Ebina, K. Toda et al. Multifocality and progression of papillary thyroid microcarcinoma during active surveillance. World J. Surg. 45, 2769\u20132776 (2021). https:\/\/doi.org\/10.1007\/s00268-021-06185-2","journal-title":"World J. Surg."},{"key":"3812_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","volume":"143","author":"RM Tuttle","year":"2017","unstructured":"R.M. Tuttle, J.A. Fagin, G. Minkowitz et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol. Head Neck Surg. 143, 1015\u20131020 (2017). https:\/\/doi.org\/10.1001\/jamaoto.2017.1442","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"3812_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/cen.13322","volume":"86","author":"MJ Jeon","year":"2017","unstructured":"M.J. Jeon, M.S. Chung, H. Kwon et al. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis. Clin. Endocrinol. 86, 845\u2013851 (2017). https:\/\/doi.org\/10.1111\/cen.13322","journal-title":"Clin. Endocrinol."},{"key":"3812_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/thy.2015.0429","volume":"26","author":"S Siddiqui","year":"2016","unstructured":"S. Siddiqui, M.G. White, T. Antic et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid 26, 807\u2013815 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0429","journal-title":"Thyroid"},{"key":"3812_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.surg.2019.05.035","volume":"166","author":"A Zambeli-Ljepovi\u0107","year":"2019","unstructured":"A. Zambeli-Ljepovi\u0107, F. Wang, M.A. Dinan et al. Extent of surgery for low-risk thyroid cancer in the elderly: equipoise in survival but not in short-term outcomes. Surgery 166, 895\u2013900 (2019). https:\/\/doi.org\/10.1016\/j.surg.2019.05.035","journal-title":"Surgery"},{"key":"3812_CR33","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1210\/jc.2012-1083","volume":"97","author":"DS McLeod","year":"2012","unstructured":"D.S. McLeod, K.F. Watters, A.D. Carpenter et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J. Clin. Endocrinol. Metab. 97, 2682\u20132692 (2012). https:\/\/doi.org\/10.1210\/jc.2012-1083","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.surg.2019.02.024","volume":"167","author":"NG Nicolson","year":"2020","unstructured":"N.G. Nicolson, T.C. Brown, R. Korah et al. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis. Surgery 167, 66\u201372 (2020). https:\/\/doi.org\/10.1016\/j.surg.2019.02.024","journal-title":"Surgery"},{"key":"3812_CR35","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.6004\/jnccn.2014.0169","volume":"12","author":"RM Tuttle","year":"2014","unstructured":"R.M. Tuttle, R.I. Haddad, D.W. Ball et al. Thyroid carcinoma, version 2.2014. J. Natl Compr. Cancer Netw. 12, 1671\u20131680 (2014). https:\/\/doi.org\/10.6004\/jnccn.2014.0169","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"3812_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fendo.2020.00265","volume":"11","author":"J Mao","year":"2020","unstructured":"J. Mao, Q. Zhang, H. Zhang et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front. Endocrinol. 11, 265 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.00265","journal-title":"Front. Endocrinol."},{"key":"3812_CR37","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1089\/thy.2013.0588","volume":"24","author":"R Paparodis","year":"2014","unstructured":"R. Paparodis, S. Imam, K. Todorova-Koteva et al. Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer. Thyroid 24, 1107\u20131114 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0588","journal-title":"Thyroid"},{"key":"3812_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801925","volume":"13","author":"J Xu","year":"2022","unstructured":"J. Xu, K. Ding, L. Mu et al. Hashimoto\u2019s thyroiditis: a \u201cdouble-edged sword\u201d in thyroid carcinoma. Front. Endocrinol. 13, 801925 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.801925","journal-title":"Front. Endocrinol."},{"key":"3812_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-021-00117-x","volume":"14","author":"P Abbasgholizadeh","year":"2021","unstructured":"P. Abbasgholizadeh, A. Naseri, E. Nasiri et al. Is Hashimoto thyroiditis associated with increasing risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid Res. 14, 26 (2021). https:\/\/doi.org\/10.1186\/s13044-021-00117-x","journal-title":"Thyroid Res."},{"key":"3812_CR40","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.1007\/s13277-015-4534-4","volume":"37","author":"N Qu","year":"2016","unstructured":"N. Qu, L. Zhang, D.Z. Lin et al. The impact of coexistent Hashimoto\u2019s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma. Tumour Biol. 37, 7685\u20137692 (2016). https:\/\/doi.org\/10.1007\/s13277-015-4534-4","journal-title":"Tumour Biol."},{"key":"3812_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/jc.2010-1624","volume":"96","author":"EL Mazzaferri","year":"2011","unstructured":"E.L. Mazzaferri, Approach to the pregnant patient with thyroid cancer. J. Clin. Endocrinol. Metab. 96, 265\u2013272 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1624","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR42","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/jcem-73-4-824","volume":"73","author":"M Ballabio","year":"1991","unstructured":"M. Ballabio, M. Poshychinda, R.P. Ekins, Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J. Clin. Endocrinol. Metab. 73, 824\u2013831 (1991). https:\/\/doi.org\/10.1210\/jcem-73-4-824","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3812_CR43","first-page":"358","volume":"31","author":"B Gibelli","year":"2011","unstructured":"B. Gibelli, P. Zamperini, M. Proh et al. Management and follow-up of thyroid cancer in pregnant women. Acta Otorhinolaryngol. Ital. 31, 358\u2013365 (2011)","journal-title":"Acta Otorhinolaryngol. Ital."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03812-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03812-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03812-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T02:17:30Z","timestamp":1723256250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03812-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3812"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03812-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}